𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy

✍ Scribed by Carolin Manthey; Ansgar W. Lohse; Andrea Pace


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
40 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Splenic tuberculosis in a patient with C
✍ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).

Severe Legionella pneumophila pneumonia
✍ Florian Beigel; Matthias JΓΌrgens; Levent Filik; Lutz Bader; Christian LΓΌck; Burk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Effects of infliximab therapy on abdomin
✍ Erika Parmentier-Decrucq; Alain Duhamel; Olivier Ernst; Catherine Fermont; Alexa πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132

Lewis and Sumner syndrome following infl
✍ Stephane Nancey; FranΓ§oise Bouhour; Gilles Boschetti; Christophe Magnier; Pierre πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o